Objectives
To examine whether it is more efficacious to commence exercise medicine in men with prostate cancer at the onset of
androgen‐deprivation therapy (ADT)
rather than later on during treatment to preserve bone and soft‐tissue composition, as
ADT
results in adverse effects including: reduced bone mineral density (
BMD
), loss of muscle mass, and increased fat mass (FM).
Patients and methods
In all, 104 patients with prostate cancer, aged 48–84 years initiating
ADT,
were randomised to immediate exercise (
IMEX
,
n
= 54) or delayed exercise (
DEL
,
n
= 50) conditions. The former consisted of 6 months of supervised resistance/aerobic/impact exercise and the latter comprised 6 months of usual care followed by 6 months of the identical exercise programme. Regional and whole body
BMD
, lean mass (LM), whole body FM and trunk FM, and appendicular skeletal muscle (
ASM
) were assessed by dual X‐ray absorptiometry, and muscle density by peripheral quantitative computed tomography at baseline, and at 6 and 12 months.
Results
There was a significant time effect (
P
< 0.001) for whole body, spine and hip
BMD
with a progressive loss in the
IMEX
and
DEL groups
, although lumbar spine
BMD
was largely preserved in the
IMEX
group at 6 months compared with the
DEL
group (−0.4% vs −1.6%). LM,
ASM
, and muscle density were preserved in the
IMEX
group at 6 months, declined in the
DEL
group at 6 months (−1.4% to −2.5%) and then recovered at 12 months after training. FM and trunk FM increased (
P
< 0.001) over the 12‐month period in the
IMEX
(7.8% and 4.5%, respectively) and
DEL
groups (6.5% and 4.3%, respectively).
Conclusions
Commencing exercise at the onset of
ADT
preserves lumbar spine
BMD
, muscle mass, and muscle density. To avoid treatment‐related adverse musculoskeletal effects, exercise medicine should be prescribed and commenced at the onset of
ADT
.